Skip Navigation

Neuro-Oncology 2008 10(5):725-733; doi:10.1215/15228517-2008-033
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sawamura, Y.
Right arrow Articles by Fujimaki, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sawamura, Y.
Right arrow Articles by Fujimaki, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright 2008 by the Society for Neuro-Oncology

Role of surgery for optic pathway/hypothalamic astrocytomas in children

Yutaka Sawamura, Kyousuke Kamada, Yuuta Kamoshima, Shigeru Yamaguchi, Toshihiro Tajima, Junko Tsubaki and Takamitsu Fujimaki

Departments of Neurosurgery (Y.S., K.K., Y.K., S.Y.) and Pediatrics (T.T., J.T.), Hokkaido University Hospital, Sapporo; Department of Neurosurgery, Teikyo University Hospital, Tokyo (T.F.); Japan

Address correspondence to Yutaka Sawamura, Department of Neurosurgery, Hokkaido University Hospital, North-15, West-7, Kita-ku, Sapporo 060-8638, Japan (ysawamu{at}med.hokudai.ac.jp).


   Abstract

Optic pathway/hypothalamic pilocytic astrocytomas in children are usually treated with chemotherapy following a surgical biopsy. In this report, we retrospectively considered the role of surgical intervention. In a series of 25 patients without neurofibromatosis type 1, the median age at initial treatment was 3.1 years (range, 0–15 years). Twenty cases were verified by histology, and five cases were diagnosed by MRI findings. Twenty-three patients received chemotherapy. All patients were alive at median follow-up of 66 months. Aims of surgery at the initiation of treatment were biopsy in 12 cases (1 stereotactic and 11 craniotomies) and debulking in 7 cases. The 11 open biopsies revealed pilocytic astrocytoma; however, noticeable complications occurred in five children after the biopsies. Review of preoperative MRIs showed that all had typical findings indicating pilocytic astrocytoma. The open biopsy offered no noteworthy benefit for the patients despite surgical risk and delay of chemotherapy. The extent of the seven resection surgeries was 70% or less removal, and postoperative adjuvant therapy was needed for six of the seven patients. The remaining six children who did not undergo surgery obtained remission with chemotherapy alone. After relapse in nine patients, 15 bulk-reduction surgeries were performed. Surgical resection was not curative in any patient. In five patients, mostly older children, cystic expansion of tumor was partially resected, resulting in additional remission. In conclusion, considering the risk of open surgery and the effectiveness of chemotherapy, the role of surgical intervention is restricted to bulk-reduction surgery only when it is inevitable, especially at relapse after chemotherapy.

Keywords: biopsy, hypothalamus, optic pathway, pilocytic astrocytoma, surgical removal

Received August 30, 2007; Accepted December 13, 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
Y. Sawamura, Y. Kamoshima, T. Kato, T. Tajima, and J. Tsubaki
Chemotherapy with Cisplatin and Vincristine for Optic Pathway/Hypothalamic Astrocytoma in Young Children
Jpn. J. Clin. Oncol., May 1, 2009; 39(5): 277 - 283.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.